Skip to main content
Kent Academic Repository

Browse by Person (creator, editor, contributor, etc.)

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: Article
Number of items: 1.

Article

Walton, Mike I. and Eve, Paul D. and Hayes, Angela and Henley, Alan T. and Valenti, Melanie R. and De Haven Brandon, Alexis K. and Boxall, Kathy J. and Box, Gary and Tall, Matthew and Swales, Karen and Matthews, Thomas P. and McHardy, Tatiana and Lainchbury, Michael and Osborne, James and Hunter, Jill E. and Perkins, Neil D. and Aherne, G. Wynne and Reader, John C. and Raynaud, Florence I. and Eccles, Suzanne A. and Collins, Ian and Garrett, Michelle D. (2015) The clinical development candidate CCT245737 is an orally active CHK1 inhibitor with preclinical activity in RAS mutant NSCLC and Eµ-MYC driven B-cell lymphoma. Oncotarget, 7 (3). pp. 2329-2342. E-ISSN 1949-2553. (doi:https://doi.org/10.18632/oncotarget.4919) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided)

This list was generated on Wed May 8 06:16:41 2019 BST.